Merck & Co. stock at EUR 130.41, market cap USD 360.8 billion

Published on 10/09/2026 at 20:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Merck & Co. stock was EUR 130.41 on October 9, 2026, up 3.07 percent from EUR 126.52. Third-quarter earnings call is set for October 29, 2026.

Key points in brief

Merck & Co. stock was trading at EUR 130.41 at Lang & Schwarz on October 9, 2026, up 3.07 percent versus the prior close.
Merck's market capitalization was USD 360.8 billion, while its primary-exchange price was USD 146.10.
The stock's primary-exchange 52-week range was USD 82.01 to USD 156.92, with 4,265,003 shares traded.
Merck's third-quarter 2026 earnings call is scheduled for October 29, 2026.

Schwarzweiß-Dokumentarfoto einer pharmazeutischen Produktionslinie mit Arbeitern — Schwarzweiß-Reportage aus Produktionsanlage illustriert Pharmasektor von Merck & Co. Inc., ISIN US58933Y1055, dokumentarisch fotografiert, Illustration mit AI erstellt.

Merck & Co. stock (ISIN US58933Y1055) was trading at EUR 130.41 at Lang & Schwarz on October 9, 2026 at 8:10 p.m. CEST, up 3.07 percent versus the prior close. The company's market capitalization was USD 360.8 billion.

After-hours price and turnover

The Lang & Schwarz bid was EUR 130.30 and the ask was EUR 130.52 at the same timestamp. On the NYSE, Merck was last at USD 146.10 on October 9, 2026 at 2:11 p.m. ET, with 4,265,003 shares traded against an average volume of 9,792,551.

The primary-exchange price stood 6.89 percent below the 52-week high of USD 156.92 and 78.15 percent above the 52-week low of USD 82.01. These levels place the stock well inside its annual range rather than at an extreme.

Valuation remains the key comparison

Merck's trailing P/E ratio was 116.86 on October 9, 2026. The valuation contrast is clear in the peer block: Pfizer traded at a P/E of 37.30, while Bristol-Myers Squibb traded at 13.12.

According to GuruFocus on October 8, 2026, Cantor Fitzgerald kept Merck at Neutral and raised its price target from USD 120.00 to USD 145.00. The new target was 0.76 percent below the NYSE price of USD 146.10 at the time of the finance quote, a comparison that points to a more cautious analyst stance than the day's euro-market move.

Comparison with peers

Merck & Co.: plus 3.07 percent, P/E 116.86, market capitalization USD 360.8 billion

Pfizer (NYSE, USD): plus 1.46 percent, P/E 37.30, market capitalization USD 160.9 billion

Bristol-Myers Squibb (NYSE, USD): plus 0.03 percent, P/E 13.12, market capitalization USD 121.7 billion

Next earnings date is October 29

According to Merck in its October 1, 2026 release, the company will hold its third-quarter 2026 sales and earnings conference call on October 29 at 9:00 a.m. ET. The date is the next clearly scheduled reporting event in the company's calendar.

Merck stock after-hours

Merck & Co. was trading at EUR 130.41 at Lang & Schwarz on October 9, 2026 at 8:10 p.m. CEST, plus 3.07 percent versus the Lang & Schwarz prior close of EUR 126.52.The continuously updated real-time quote of Merck & Co. stock provides the latest trading view.